The legacy market is seeing a significant recent trend with transactions that do not involve the typical transfer or reinsurance of lines of insurance business but significant restructurings by large corporates with a view to selling entities (not insurance regulated) to provide finality to those corporations of underlying legacy liabilities. This panel will discuss the drivers of these deals, the benefits for sellers, the evolving market and opportunity for buyers (including traditional run-off players), structuring issues and deal terms.